Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress
Journal of Pharmacy and Pharmacology · 2024
DOI: 10.1093/jpp/rgae049 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2024. Verfasst von Ananyaa Sridhar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland BT52 1SA, United Kingdom. Hauptthemen laut MEDLINE: Dopamine, Signal Transduction, Diet, High-Fat, Insulin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Ireland Department, Northern Ireland Department for the Economy, Ulster University Strategic Funding.
Abstract (Originalsprache)
Objectives
Dopamine and related receptors are evidenced in pancreatic endocrine tissue, but the impact on islet β-cell stimulus-secretion as well as (patho)physiological role are unclear.
Methods
The present study has evaluated islet cell signalling pathways and biological effects of dopamine, as well as alterations of islet dopamine in rodent models of diabetes of different aetiology. Key findings The dopamine precursor l-DOPA partially impaired glucose tolerance in mice and attenuated glucose-, exendin-4, and alanine-induced insulin secretion. The latter effect was echoed by the attenuation of glucose-induced [Ca2+]i dynamics and elevation of ATP levels in individual mouse islet cells. l-DOPA significantly decreased β-cell proliferation rates, acting predominantly via the D2 receptor, which was most abundant at the mRNA level. The administration of streptozotocin (STZ) or high-fat diet (HFD) in mice significantly elevated numbers of dopamine-positive islet cells, with HFD also increasing colocalization of dopamine with insulin. At the same time, colocalization of dopamine with glucagon was increased in STZ-treated and pregnant mice, but unaffected by HFD.
Conclusion
These findings highlight a role for dopamine receptor signalling in islet cell biology adaptations to various forms of metabolic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Diabetes Research Centre, Biomedical Sciences Research Institute, Ulster University, Coleraine, Northern Ireland BT52 1SA, United Kingdom.
ORCID-Profile: Nigel Irwin
Förderung
- Northern Ireland Department
- Northern Ireland Department for the Economy
- Ulster University Strategic Funding
- Vice Chancellors Research Studentship
- RD Lawrence Fellowship
- Diabetes UK
Zitieren
APA
Sridhar, A., Flatt, P. R., Draper, M., Tarasov, A. I., Moffett, R. C., Irwin, N., & Khan, D. (2024). Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgae049
Vancouver
Sridhar A, Flatt PR, Draper M, Tarasov AI, Moffett RC, Irwin N, et al. Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress. Journal of Pharmacy and Pharmacology. 2024. doi:10.1093/jpp/rgae049
BibTeX
@article{Sridhar2024,
author = {Sridhar, Ananyaa and Flatt, Peter R and Draper, Matthew and Tarasov, Andrei I and Moffett, R Charlotte and Irwin, Nigel and Khan, Dawood},
title = {Dopamine signalling in pancreatic islet cells and role in adaptations to metabolic stress},
journal = {Journal of Pharmacy and Pharmacology},
year = {2024},
doi = {10.1093/jpp/rgae049}
}
EUVIMED